ResMed, Koninklijke Philips N.V. and Fisher & Paykel Healthcare Limited are Dominating the Global Sleep Apnea Devices Market in 2021

Global Sleep Apnea Devices Market is expected to grow with the CAGR of 7.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-sleep-apnea-devices-market

Global sleep apnea devices market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global sleep apnea devices market are introducing strong range of devices and therapy provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In November 2019, ResMed launched its product named AirFit P30i, a new nasal pillow for treating sleep apnea. This new product launched by the company has increased its demand and sales in the market leading to increased revenue in future.

ResMed is the dominating player in global sleep apnea devices market. The other major players operating in this market are Koninklijke Philips N.V., Itamar Medical Ltd., Natus Medical Incorporated, CONTEC MEDICAL SYSTEMS CO.,LTD, BMC Medical Co., Ltd., SomnoMed,  Fisher & Paykel Healthcare Limited, Medicom MTD Ltd, Somnowell, Compumedics Limited, SIBELMED, APEX MEDICAL CORP., Inspire Medical Systems, Inc., NIHON KOHDEN CORPORATION., DeVilbiss Healthcare LLC, nox medical, Advanced Brain Monitoring, Inc, Cleveland Medical Devices Inc., Braebon Medical Corporation, Lowenstein Medical Technology GmbH + Co. KG., and Nyxoah SA among others.

Sleep Apnea Devices MarketResMed

ResMed was founded in the year 1989 and is headquartered in California, U.S. The company is exclusively focusing in offering the cloud-connected medical devices that transform care for people with sleep apnea, COPD and other chronic diseases. The company operates its business via several business segments including sleep and respiratory care segment and SaaS segment in which sleep and respiratory care segment are the market focused segment. The company has several product categories including sleep apnea, portable oxygen and ventilation, in which sleep apnea is the market focused category.

For instance,

  • In November 2019, ResMed launched its product named AirFit P30i, a new nasal pillow for treating sleep apnea. This new product launched by the company has increased its demand and sales in the market leading to increased revenue in future. The company has wide presence across North America.

The company has presence across Asia-Pacific, Europe, Middle East and Africa, South America, North America. The company also has various subsidiaries ResMed Corp. (U.S.), ResMed (EPN) Limited (U.K.), ResMed Asia Operations Pty Ltd (Australia), ResMed KK (Japan) and ResMed GmbH and Co KG (Germany) among more.

Koninklijke Philips N.V.

Koninklijke Philips N.V. was founded in the year 1891 and is headquartered in Amsterdam, Netherlands. The main focus of the company is engaged in offering diagnostic imaging, patient monitoring, image-guided therapy and health informatics and also solutions in consumer health and home care. The company operates its business via several business segments including diagnosis & treatment businesses, personal health businesses, connected care & health, other in which connected care businesses is focused segment. The company has two product categories which are for consumer, for professionals (healthcare) in which for consumer is the market focused category.

For instance,

  • In October 2020, Koninklijke Philips N.V. launched three major initiatives in India by partnered with Indian Sleep Disorders Association (ISDA) in order to address the sleep disorders. These initiatives launched by the company during the emergence of COVID-19 have increased its credibility in the market.

The company has presence across Asia-Pacific, Europe, Middle East and Africa, South America, and North America. The company also has various subsidiaries Philips GmbH (Germany), Philips Consumer Lifestyle B.V. (The Netherlands), Philips Medical Systems Nederland B.V. (The Netherlands), Philips Ultrasound, Inc. (U.S.), and Philips Oral Healthcare, LLC (U.S.) among others.

Fisher & Paykel Healthcare Limited

Fisher & Paykel Healthcare Limited was founded in the year 1969 and is headquartered in Auckland, New Zealand. Their main focus of the company is in the development of wide range of medical devices and systems for use in respiratory care, acute care, surgery and in the treatment of obstructive sleep apnea. The company is working on business segments hospital products and homecare products where homecare product is market focused segment. The company working on hospital and homecare products where homecare products are focused category.

For instance,

  • In October 2019, Fisher & Paykel Healthcare Limited announced the release of F&P Vitera in the U.S. This mask is for patients who are suffering from Obstructive Sleep Apnea. This mask features minimum leaks and pressure on the nose bridge. These features will increase the demand in the market and help the company to grow its sale

The company has presence across Asia-Pacific, Europe, Middle East and Africa, North America and South America. The company also has various subsidiaries including Fisher & Paykel Australia Holdings Pty Ltd. (New Zealand), Dynamic Cooking Systems, Inc (U.S.), Fisher & Paykel Appliances (New Zealand), Prime Distributors Ltd. (U.S.), and Fisher & Paykel Appliances Ltd. (New Zealand) among others.